ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Inflammation Disrupts Memory - What Can You Do to Protect Your Brain?

All About Ginkgo Biloba: Benefits of This Timeless Herbal Supplement

Yarrow Oil: Here's Why It Deserves a Place in Your First-Aid Kit

Artificial sweeteners linked to risk of weight gain, heart disease and other health issues

Trial Finds Reduction in Depressive Symptoms Following Magnesium Supplementation

Vitamin D supplement use associated with lower risk of breast cancer

Carnitine deficiency suggested as contributor to autism

Hop Oil: A Safe Sleep Aide

White Camphor Oil: The Purest Camphor Oil

Lutein — An Important Nutrient for Eye and Brain Health

 
Print Page
Email Article

Duloxetine May Be Effective for Treatment of Fibromyalgia Symptoms

  [ 374 votes ]   [ Discuss This Article ]
www.ProHealth.com • March 10, 2004


DGDispatch Source: Doctor’s Guide
By Jerry Ingram ORLANDO, FL -- March 5, 2004 -- Duloxetine, a drug being studied for treatment of depression, appears to be an effective and safe treatment for symptoms of fibromyalgia in patients with or without major depressive disorder (MDD), especially women, researchers said here on March 4th at the American Academy of Pain Medicine 20th Annual Meeting. "We found that duloxetine has a direct effect on pain, which is not merely associated with treatment for depression," said Madelaine Wohlreich, MD, Clinical Research Physician, Eli Lilly and Company, Indianapolis, Indianapolis, United States. "Depression is very frequently accompanied by painful symptoms and by showing that we can affect painful symptoms with or without depression. It adds credibility to the fact that this drug might in fact offer something to depressed patients in particular." For this trial, investigators enrolled 207 patients in a 12-week study, who received a single-blind placebo was administered in the first week and were then randomized to duloxetine 120 mg/daily or placebo. Primary outcome measures were assessed using the Fibromyalgia Impact Questionnaire (FIQ) total score and pain score. Patients were also evaluated with the Clinical Global Impression of Severity, Patient Global Impression of Improvement, Brief Pain Inventory, Short Form (SF)-36, Quality of Life in Depression Scale and the Sheehan Disability Scale. Researchers found that subjects treated with duloxetine improved more than placebo-treated patients on the FIQ total score, with a treatment difference of -5.53 (P = .027), but did not show significant improvement on the FIQ pain score. Subjects treated with duloxetine also had greater reduction in Brief Pain Inventory (BPI) average severity score (P = .008), BPI average interference from pain score (P = .004), tender point number (P = .022), and FIQ stiffness score (P = .048). Duloxetine treatment also reported improvement Clinical Global Impression of Severity scores as well as superior results in quality of life according to Patient Global Impression of Improvement scores. The investigators noted that women in particular showed significantly greater improvement on virtually all efficacy measures compared with placebo-treated women. Men, however, did not show improvement on any efficacy measures. Dr. Wohlreich and her associates concluded that duloxetine is an effective and safe treatment for many of the symptoms associated with fibromyalgia, particularly for women, who comprise the majority of this patients group. [Study title: A Double-blind Trial Comparing Duloxetine to Placebo in the Treatment of Fibromyalgia with or without Major Depressive Disorder. Poster 166] (c) 1995-2004 Doctor's Guide Publishing Limited. All rights reserved.



Post a Comment

Featured Products From the ProHealth Store
Mitochondria Ignite™ with NT Factor® Ultra EPA  - Fish Oil Optimized Curcumin Longvida®


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%

Natural Remedies

Can Autoimmune Conditions be Reversed? Researchers Make a Surprising Discovery Can Autoimmune Conditions be Reversed? Researchers Make a Surprising Discovery
Soothe, Heal and Regulate Your Digestive System with Nutrient-Rich Aloe Vera Soothe, Heal and Regulate Your Digestive System with Nutrient-Rich Aloe Vera
Milk Thistle: Trusted Support for Health & Healing in a Toxic World Milk Thistle: Trusted Support for Health & Healing in a Toxic World
Restoring Gut Health: How to Create a Firewall Against Toxins Entering the Gut Wall Restoring Gut Health: How to Create a Firewall Against Toxins Entering the Gut Wall
Health Benefits Are Brewing in Green Tea Health Benefits Are Brewing in Green Tea

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map